Rothschild Investment LLC’s Ginkgo Bioworks DNA Stock Holding History

Rothschild Investment LLC’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.06K	Buy	208 +176	+550%	+$1.47K	﹤0.01%	2752
2026 Q1	$196	Buy	32 +18	+129%	+$150	﹤0.01%	3307
2025 Q4	$116	Buy	+14	New	+$151	﹤0.01%	3191
2024 Q3	–	Sell	-1,548	Closed	-$20.7K	–	2920
2024 Q2	$20.7K	Hold	1,548	–	–	﹤0.01%	964
2024 Q1	$71.8K	Hold	1,548	–	–	0.01%	665
2023 Q4	$105K	Hold	1,548	–	–	0.01%	524
2023 Q3	$112K	Hold	1,548	–	–	0.01%	459
2023 Q2	$115K	Hold	1,548	–	–	0.01%	472
2023 Q1	$82K	Hold	1,548	–	–	0.01%	472
2022 Q4	$105K	Buy	+1,548	New	+$142K	0.01%	463

Other funds holding DNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Rothschild Investment LLC's DNA Position: Q2 2026 in Review

Rothschild Investment LLC increased its Ginkgo Bioworks (DNA) stake by 550% in Q2 2026, buying an estimated $1.47K and bringing the position to 208 shares worth $2.06K. The position accounts for ﹤0.01% of the portfolio, ranked #2752.

Rothschild Investment LLC first reported a position in DNA in Q4 2022 and has held it in 10 quarters since. The position peaked at $115K in Q2 2023. 67 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

Rothschild Investment LLC held 208 shares of Ginkgo Bioworks worth $2.06K as of Q2 2026.
Rothschild Investment LLC bought 176 Ginkgo Bioworks shares in Q2 2026, an estimated $1.47K.
Ginkgo Bioworks made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2752 holding.
Rothschild Investment LLC first reported a position in Ginkgo Bioworks in Q4 2022 and has held it in 10 quarters since.
Rothschild Investment LLC's Ginkgo Bioworks position peaked at $115K in Q2 2023.
67 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.